RADX EBITDA

RADX Annual EBITDA

-$28.90 M
-$7.91 M-37.72%

01 June 2024

RADX EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RADX EBITDA Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-37.7%--
3 y3 years-121.9%--
5 y5 years-121.9%--

RADX EBITDA High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-121.9%at low
5 y5-year-121.9%at low
alltimeall time-121.9%at low

Radiopharm Theranostics Limited EBITDA History

DateAnnualQuarterlyTTM
June 2024
-$28.90 M(+37.7%)
-
-
DateAnnualQuarterlyTTM
June 2023
-$20.99 M(+61.1%)
-
-
June 2022
-$13.03 M
-
-

FAQ

  • What is Radiopharm Theranostics Limited annual earnings before interest, taxes, depreciation & amortization?
  • What is the all time high annual EBITDA for Radiopharm Theranostics Limited?
  • What is Radiopharm Theranostics Limited annual EBITDA year-on-year change?

What is Radiopharm Theranostics Limited annual earnings before interest, taxes, depreciation & amortization?

The current annual EBITDA of RADX is -$28.90 M

What is the all time high annual EBITDA for Radiopharm Theranostics Limited?

Radiopharm Theranostics Limited all-time high annual earnings before interest, taxes, depreciation & amortization is -$13.03 M

What is Radiopharm Theranostics Limited annual EBITDA year-on-year change?

Over the past year, RADX annual earnings before interest, taxes, depreciation & amortization has changed by -$7.91 M (-37.72%)